Silvio Melo Torres

13PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Haematological tumoursPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 03, 2026
Size alone is not enough: Ki-67 and invasion patterns identify high-risk pancreatic neuroendocrine tumors.

|Sep 19, 2024
Impact of Minimally Invasive Surgery on Early and Late Outcomes of Patients With Gastric Cancer Treated Using Neoadjuvant Chemotherapy.

Gustavo Ferreira Araruna, Heber S C Ribeiro, Silvio M Torres

|Aug 14, 2024
Modified laparoscopic transthoracic hepatectomy for upper liver segments: Technique, indications, and early outcomes.

Silvio M Torres, Matheus C Prudente, Heber S C Ribeiro

|Aug 06, 2024
Influence of biliary and vascular resection types on morbidity in hepatectomies with vascular involvement.

Jonatha C F da Silva, Alessandro L Diniz, Silvio M Torres

|Jul 01, 2024
Dense tumor-infiltrating lymphocytes (TILs) in liver metastasis from colorectal cancer are related to improved overall survival.

Diego Greatti Vaz da Silva, Heber Salvador de Castro de Ribeiro, Gabriel Oliveira Dos Santos

|Oct 05, 2023
Current clinical practice in the management of Brazilian patients with potentially resectable pancreatic ductal adenocarcinoma (PDAC).

Victor Hugo Fonseca de Jesus, Renata D'Alpino Peixoto, Héber Salvador de Castro Ribeiro

Pageof 3

Frequent Collaborators

8 joint publications

Wilson Luiz da Costa Junior

6 joint publications

Heber Salvador de Castro Ribeiro

4 joint publications

Dante Altenfelder Silva Mesquita Cortelli

4 joint publications

Victor Hugo Fonseca de Jesus